Generation Bio Cash Flow from Investing Activities 2020-2023 | GBIO
Generation Bio Annual Cash Flow Investing (Millions of US $) |
|
---|---|
2023 | $-10 |
2022 | $-193 |
2021 | $193 |
2020 | $-205 |
2019 | $48 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Generic Drugs | $0.244B | $0.006B |
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Teva Pharmaceutical Industries (TEVA) | Israel | $18.263B | 6.36 |
Dr Reddy's Laboratories (RDY) | India | $11.391B | 16.94 |
BridgeBio Pharma (BBIO) | United States | $5.631B | 0.00 |
Aspen Pharmacare (APNHY) | South Africa | $5.621B | 0.00 |
Bausch Health Cos (BHC) | Canada | $2.483B | 1.89 |
Amphastar Pharmaceuticals (AMPH) | United States | $2.126B | 12.79 |
Supernus Pharmaceuticals (SUPN) | United States | $1.600B | 0.00 |
Taysha Gene Therapies (TSHA) | United States | $0.578B | 0.00 |
Assembly Biosciences (ASMB) | United States | $0.080B | 0.00 |
Personalis (PSNL) | United States | $0.073B | 0.00 |
Acasti Pharma (ACST) | Canada | $0.025B | 0.00 |
Sol-Gel Technologies (SLGL) | Israel | $0.021B | 0.00 |
Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
Teligent (TLGT) | United States | $0.000B | 0.00 |